Immunological protein expression profile in Ccl2/Cx3cr1 deficient mice with lesions similar to age-related macular degeneration

Experimental Eye Research

Volumn 86, Issue 4, 2008, Pages 675-683

  Ross, Robert J ^a   Zhou, Min ^a   Shen, Defen ^a   Fariss, Robert N ^a   Ding, Xiaoyan ^a,b   Bojanowski, Christine M ^a   Tuo, Jingsheng ^a   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

age related macular degeneration; animal model; chemokine; complement factor; cytokine; macrophage; microglia; toll like receptor 4

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INNATE IMMUNITY; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; AUTOANTIBODIES; BRUCH MEMBRANE; CAPILLARIES; CHEMOKINE CCL2; CHOROID; COMPLEMENT C3; COMPLEMENT C3D; DISEASE MODELS, ANIMAL; GENE EXPRESSION; MACROPHAGES; MACULAR DEGENERATION; MICE; MICE, KNOCKOUT; MICROGLIA; PIGMENT EPITHELIUM OF EYE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CHEMOKINE; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; UVEITIS;

EID: 41049102336     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.01.014     Document Type: Article

References (46)

1. Ambati J., Anand A., Fernandez S., Sakurai E., Lynn B.C., Kuziel W.A., Rollins B.J., and Ambati B.K. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat. Med. 9 (2003) 1390-1397
2. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., and Schwartz D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25 (2000) 187-191
3. Augustin A.J., and Offermann I. Emerging drugs for age-related macular degeneration. Expert. Opin. Emerg. Drugs 11 (2006) 725-740
4. Baudouin C., Peyman G.A., Fredj-Reygrobellet D., Gordon W.C., Lapalus P., Gastaud P., and Bazan N.G. Immunohistological study of subretinal membranes in age-related macular degeneration. Jpn. J. Ophthalmol. 36 (1992) 443-451
5. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., Lee J.C., Cook D.N., Jung S., Lira S.A., Littman D.R., and Ransohoff R.M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9 (2006) 917-924
6. Chan C.C., Palestine A.G., Nussenblatt R.B., Roberge F.G., and Benezra D. Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. Ophthalmology 92 (1985) 1025-1028
7. Combadiere C., Potteaux S., Gao J.L., Esposito B., Casanova S., Lee E.J., Debre P., Tedgui A., Murphy P.M., and Mallat Z. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice 4. Circulation 107 (2003) 1009-1016
8. Combadiere C., Feumi C., Raoul W., Keller N., Rodero M., Pezard A., Lavalette S., Houssier M., Jonet L., Picard E., Sirinyan M., Deterre P., Ferroukhi T., Cohen S.-Y., Chauvaud D., Jeanny J., Chemtob S., Behar-Cohen C.F., and Sennlaub F. CX3CR1 dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J. Clin. Invest. 117 (2007) 2920-2928
9. Edfeldt K., Swedenborg J., Hansson G.K., and Yan Z.Q. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105 (2002) 1158-1161
10. Edwards A.O., Ritter I.R., Abel K.J., Manning A., Panhuysen C., and Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
11. Fan H., Williams D.L., Zingarelli B., Breuel K.F., Teti G., Tempel G.E., Spicher K., Boulay G., Birnbaumer L., Halushka P.V., and Cook J.A. Differential regulation of lipopolysaccharide and Gram-positive bacteria induced cytokine and chemokine production in splenocytes by G[alpha]i proteins. Biochim. Biophys. Acta (BBA) - Mol. Cell Res. 1763 (2006) 1051-1058
12. Friedman D.S., O'Colmain B.J., Munoz B., Tomany S.C., McCarty C., de Jong P.T., Nemesure B., Mitchell P., and Kempen J. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 122 (2004) 564-572
13. Geissmann F., Jung S., and Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19 (2003) 71-82
14. Gold B., Merriam J.E., Zernant J., Hancox L.S., Taiber A.J., Gehrs K., Cramer K., Neel J., Bergeron J., Barile G.R., Smith R.T., Hageman G.S., Dean M., and Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 38 (2006) 458-462
15. Grossniklaus H.E., Miskala P.H., Green W.R., Bressler S.B., Hawkins B.S., Toth C., Wilson D.J., and Bressler N.M. Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7. Arch. Ophthalmol. 123 (2005) 914-921
16. Gu X., Meer S.G., Miyagi M., Rayborn M.E., Hollyfield J.G., Crabb J.W., and Salomon R.G. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J. Biol. Chem. 278 (2003) 42027-42035
17. Gupta N., Brown N.E., and Milam A.H. Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp. Eye Res. 76 (2003) 463-471
18. Hageman G.S., Luthert P.J., Victor Chong N.H., Johnson L.V., Anderson D.H., and Mullins R.F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Rest. Eye Res. 20 (2001) 705-732
19. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchardt J.D., Gehrs K.M., Smith R.J., Silvestri G., Russell S.R., Klaver C.C., Barbazetto I., Chang S., Yannuzzi L.A., Barile G.R., Merriam J.C., Smith R.T., Olsh A.K., Bergeron J., Zernant J., Merriam J.E., Gold B., Dean M., and Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 102 (2005) 7227-7232
20. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., and Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
21. Johnson P.T., Betts K.E., Radeke M.J., Hageman G.S., Anderson D.H., and Johnson L.V. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc. Natl. Acad. Sci. USA 103 (2006) 17456-17461
22. Kindzelskii A.L., Elner V.M., Elner S.G., Yang D., Hughes B.A., and Petty H.R. Toll-like receptor 4 (TLR4) of retinal pigment epithelial cells participates in transmembrane signaling in response to photoreceptor outer segments. J. Gen. Physiol. 124 (2004) 139-149
23. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., Sangiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., and Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
24. Li Q., Peng B., Whitcup S.M., Jang S.U., and Chan C.C. Endotoxin induced uveitis in the mouse: susceptibility and genetic control. Exp. Eye Res. 61 (1995) 629-632
25. Li M., Atmaca-Sonmez P., Othman M., Branham K.E., Khanna R., Wade M.S., Li Y., Liang L., Zareparsi S., Swaroop A., and Abecasis G.R. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat. Genet. 38 (2006) 1049-1054
26. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., North R., Gerard C., and Rollins B.J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187 (1998) 601-608
27. Maller J., George S., Purcell S., Fagerness J., Altshuler D., Daly M.J., and Seddon J.M. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat. Genet. 38 (2006) 1055-1059
28. Negi V.S., Aggarwal A., Dayal R., Naik S., and Misra R. Complement degradation product C3d in urine: marker of lupus nephritis. J. Rheumatol. 27 (2000) 380-383
29. Nielsen C.H., and Leslie R.G.Q. Complement's participation in acquired immunity. J. Leukoc. Biol. 72 (2002) 249-261
30. Patel N., Ohbayashi M., Nugent A.K., Ramchand K., Toda M., Chau K.Y., Bunce C., Webster A., Bird A.C., Ono S.J., and Chong V. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 115 (2005) 422-430
31. Penfold P.L., Killingsworth M.C., and Sarks S.H. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch. Clin. Exp. Ophthalmol. 223 (1985) 69-76
32. Resnikoff S., Pascolini D., Etya'ale D., Kocur I., Pararajasegaram R., Pokharel G.P., and Mariotti S.P. Global data on visual impairment in the year 2002. Bull. World Health Organ 82 (2004) 844-851
33. Riedemann N.C., Guo R.F., Sarma V.J., Laudes I.J., Huber-Lang M., Warner R.L., Albrecht E.A., Speyer C.L., and Ward P.A. Expression and function of the C5a receptor in rat alveolar epithelial cells. J. Immunol. 168 (2002) 1919-1925
34. Ross R.J., Bojanowski C.M., Wang J.J., Chew E.Y., Rotchina E., Ferris F.R., Mitchell P., Chan C.C., and Tuo J. The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples. Invest. Ophthalmol. Vis. Sci. 48 (2007) 1128-1132
35. Shen D.F., Buggage R.R., Eng H.C., and Chan C.C. Cytokine gene expression in different strains of mice with endotoxin-induced uveitis (EIU). Ocul. Immunol. Inflamm. 8 (2000) 221-225
36. Sivaprasad S., Bailey T.A., and Chong V.N. Bruch's membrane and the vascular intima: is there a common basis for age-related changes and disease?. Clin. Exp. Ophthalmol. 33 (2005) 518-523
37. Soames C.J., and Sim R.B. Interactions between human complement components factor H, factor I and C3b. Biochem. J. 326 (1997) 553-561
38. The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the. United States. Arch. Ophthalmol. 122 (2004) 477-485
39. Tuaillon N., Shen d.F., Berger R.B., Lu B., Rollins B.J., and Chan C.C. MCP-1 expression in endotoxin-induced uveitis. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1493-1498
40. Tuo J., Ning B., Bojanowski C.M., Lin Z.N., Ross R.J., Reed G.F., Shen D., Jiao X., Zhou M., Chew E.Y., Kadlubar F.F., and Chan C.C. Synergic effect of polymorphisms in ERCC6 5′ flanking region and complement factor H on age-related macular degeneration predisposition. Proc. Natl. Acad. Sci. USA 103 (2006) 9256-9261
41. Tuo J., Bojanowski C.M., Zhou M., Shen D., Ross R.J., Rosenberg K.I., Cameron D.J., Yin C., Kowalak J.A., Zhuang Z., Zhang K., and Chan C.C. Murine Ccl2/Cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 48 (2007) 3827-3836
42. Umeda S., Suzuki M.T., Okamoto H., Ono F., Mizota A., Terao K., Yoshikawa Y., Tanaka Y., and Iwata T. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J. 19 (2005) 1683-1685
43. Vogt S.D., Barnum S.R., Curcio C.A., and Read R.W. Distribution of complement anaphylatoxin receptors and membrane-bound regulators in normal human retina. Exp. Eye Res. 83 (2006) 834-840
44. Wang L., Sunyer J.O., and Bello L.J. Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus. J. Virol. 78 (2004) 1616-1622
45. Xu X.H., Shah P.K., Faure E., Equils O., Thomas L., Fishbein M.C., Luthringer D., Xu X.P., Rajavashisth T.B., Yano J., Kaul S., and Arditi M. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104 (2001) 3103-3108
46. Zareparsi S., Buraczynska M., Branham K.E., Shah S., Eng D., Li M., Pawar H., Yashar B.M., Moroi S.E., Lichter P.R., Petty H.R., Richards J.E., Abecasis G.R., Elner V.M., and Swaroop A. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum. Mol. Genet. 14 (2005) 1449-1455